ANNOUNCES THE USE OF A VIRTUAL PLATFORM TO RECRUIT COVID-19 PATIENTS IN CANADA TO THE PHASE 2 TRIAL. WILL ALSO ASSESS THE IMPACT OF OMEGO ON HOSPITALISED PATIENTS WITH SEVERE FORMS OF COVID-19 IN MEXICO AND BRAZIL
24.09.2020
SHARE CAPITAL INCREASE REGISTERED
18.09.2020
New study highlights the potential of OmeGo® as a prophylactic therapy for Asthma and COPD
01.09.2020
ISSUANCE OF NEW SHARES FOLLOWING EXERCISE OF OPTIONS – PRIMARY INSIDER DISCLOSURE
28.08.2020
SECOND QUARTER & HALF YEAR 2020 FINANCIAL REPORT
SECURES DISTRIBUTION WITH A GLOBAL RETAILER GIANT IN THE UK, SPAIN, ICELAND, AND ONLINE FOR BRILLIANT SALMON OIL™ FOR PETS
27.08.2020
HBC AQUIRES A 34 PERCENT STAKE IN HEALTHCARE AND PETCARE DISTRIBUTOR ATLANTIC DELIGHTS LTD FOR ACCESS TO CHINESE MARKET
STRENGTHENS R&D FUNCTION WITH THE HIRING OF DR. ERLAND HERMANSEN AS MEDICAL DIRECTOR FOR CLINICAL DEVELOPMENT
26.08.2020
CORRECTION: SHARE CAPITAL DECREASE REGISTERED – NEW PAR VALUE
12.08.2020
SHARE CAPITAL DECREASE REGISTERED – NEW PAR VALUE